# Anderson & Collins Clinical Research Inc. – FDA Inspection, Mar 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/anderson-collins-clinical-research-inc/c9e7a126-a8e9-4a08-8afd-809676b5c632
Source feed: FDA_Inspections

> FDA inspection 1008182 of Anderson & Collins Clinical Research Inc., March 20, 2017. Classification: Official Action Indicated (OAI). 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008182
- Company Name: Anderson & Collins Clinical Research Inc.
- Inspection Date: 2017-03-20
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 791930 - 2012-07-25
- [FDA Inspection 543402 - 2008-10-21](https://www.keypedia.com/records/fda_inspections/anderson-collins-clinical-research-inc/39aa183a-9a29-4637-ad15-89a683eebc96)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anastasia-i-onuorah/d081d002-e4a4-4001-ba06-b71ff9fbf9f7)
- [Company Rep](https://www.keypedia.com/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)

Company: https://www.keypedia.com/companies/anderson-collins-clinical-research-inc/886ce127-781c-4dd1-91bf-1a8e3d6d119f

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248